ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $668,000 | -3.9% | 34,524 | -1.3% | 0.66% | +5.7% |
| Q2 2022 | $695,000 | -34.4% | 34,991 | -1.4% | 0.63% | -13.1% |
| Q1 2022 | $1,059,000 | +17.8% | 35,488 | -8.1% | 0.72% | +22.7% |
| Q4 2021 | $899,000 | -16.0% | 38,601 | +12.5% | 0.59% | -13.4% |
| Q3 2021 | $1,070,000 | +21.3% | 34,301 | +36.7% | 0.68% | +21.0% |
| Q2 2021 | $882,000 | +90.9% | 25,097 | +91.7% | 0.56% | +79.9% |
| Q1 2021 | $462,000 | +15.5% | 13,094 | +22.8% | 0.31% | +17.7% |
| Q4 2020 | $400,000 | – | 10,661 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |